• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

TARDBP Antibody – Goat Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS621586

TARDBP was identified as the disease accumulating protein in patients with frontotemporal lobar degeneration (FTLD) with ubiquitin inclusions (FTLD-U) and in amyotrophic lateral sclerosis (ALS). TARDBP functions as a DNA-binding protein and specifically binds… More details

$835 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
TARDBP, Polyclonal Antibody
Full Product Name
TARDBP (TAR DNA Binding Protein, ALS10, TDP-43, OTTHUMP00000002171, TAR DNA-binding protein-43)
Product Gene Name
Product Synonym Names
Anti -TARDBP (TAR DNA Binding Protein, ALS10, TDP-43, OTTHUMP00000002171, TAR DNA-binding protein-43)
Clonality
Polyclonal
Isotype
IgG
Host
Goat
Species Reactivity
Human
Form/Format
Supplied as a liquid in Tris saline, pH 7.3, 0.5% BSA, 0.02% sodium azide.
Purity/Purification
Affinity Purified
Purified by immunoaffinity chromatography.
Specificity
Recognizes human TARDBP. Species Sequence Homology: mouse, canine, bovine
Preparation and Storage
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Molecular Weight
44,740 Da
Chromosome Location
chromosome: 1; Location: 1p36.22
OMIM
605078
3D Structure
ModBase 3D Structure for Q13148
Immunogen
Synthetic peptide corresponding to HISNAEPKHNSNRQ from the internal region of human TARDBP (Accession #NP_031401).
Applications Tested/Suitable for anti-TARDBP antibody
ELISA (EL/EIA), Western Blot (WB)
Application Notes for anti-TARDBP antibody
Suitable for use in ELISA and Western Blot.
Dilution: Peptide ELISA: 1:16,000
Western Blot: 0.3-1ug/ml Detects ~45kD band in human Jurkat cell lysates.

Western Blot (WB) of anti-TARDBP antibody

Western Blot of Jurkat lysate (35ug protein in RIPA buffer) using MBS621586 (0.3ug/ml). Primary incubation was 1 hour. Detected by chemiluminescence.
Goat Anti-TARDBP Polyclonal Antibody – Cat# MBS621586

Other Notes

Small volumes of anti-TARDBP antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for TARDBP purchase

MBS621586 is an antibody targeting TARDBP. Also known as TARDBP (TAR DNA Binding Protein, ALS10, TDP-43, OTTHUMP00000002171, TAR DNA-binding protein-43). Reactive in Human. Host: Goat.

Additional Details

NCBI/Uniprot data below describe general gene information for TARDBP. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
TARDBP
NCBI Official Synonym Full Names
TAR DNA binding protein
NCBI Official Symbol
TARDBP
NCBI Official Synonym Symbols
ALS10; TDP-43; TARDBP
UniProt Protein Name
TAR DNA-binding protein 43
UniProt Gene Name
TARDBP
UniProt Synonym Gene Names
TDP43
UniProt Entry Name
TADBP_HUMAN
NCBI Protein Information
TAR DNA-binding protein 43; OTTHUMP00000002173; TAR DNA-binding protein-43

NCBI Summary for TARDBP

HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene is a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. In addition, this protein regulates alternate splicing of the CFTR gene. A similar pseudogene is present on chromosome 20. [provided by RefSeq]
Show more

UniProt Comments for TARDBP

TARDBP: DNA and RNA-binding protein which regulates transcription and splicing. Involved in the regulation of CFTR splicing. It promotes CFTR exon 9 skipping by binding to the UG repeated motifs in the polymorphic region near the 3'-splice site of this exon. The resulting aberrant splicing is associated with pathological features typical of cystic fibrosis. May also be involved in microRNA biogenesis, apoptosis and cell division. Can repress HIV-1 transcription by binding to the HIV-1 long terminal repeat. Stabilizes the low molecular weight neurofilament (NFL) mRNA through a direct interaction with the 3' UTR. Homodimer. Binds specifically to pyrimidine-rich motifs of TAR DNA and to single stranded TG repeated sequences. Binds to RNA, specifically to UG repeated sequences with a minimun of six contiguous repeats. Interacts with ATNX2; the interaction is RNA-dependent. Ubiquitously expressed. In particular, expression is high in pancreas, placenta, lung, genital tract and spleen. 3 isoforms of the human protein are produced by alternative splicing.

Protein type: RNA-binding

Chromosomal Location of Human Ortholog: 1p36.22

Cellular Component: nucleoplasm; perichromatin fibrils; cytoplasm; nuclear speck; nucleus

Molecular Function: identical protein binding; protein binding; mRNA 3'-UTR binding; RNA binding; double-stranded DNA binding; nucleotide binding; transcription factor activity

Biological Process: transcription from RNA polymerase II promoter; RNA splicing; positive regulation of insulin secretion; positive regulation of transcription from RNA polymerase II promoter; mRNA processing

Disease: Amyotrophic Lateral Sclerosis 10, With Or Without Frontotemporal Dementia
Show more

Research Articles on TARDBP

1. The present study showed that degeneration initiated by mutations in VCP is mediated in part through toxic gain of function of TDP-43 in the cytoplasm in a novel Drosophila model of disease.
2. characteristic clinical phenotype of familial amyotrophic lateral sclerosis with initial bulbar symptoms occurred in a family with a TDP-43 M337V substitution
3. TDP-43 plays a role in miRNA expression pathways. Let-7b and miR-663 expression levels are down- and upregulated, respectively. Both miRNAs are capable of binding directly to TDP-43 in different positions.
4. TDP-43 exerts cell-autonomous neurotoxicity in Drosophila; dose-dependent alterations of human TDP-43 nuclear function may underlie motor neuron death in ALS
5. To clarify the conformational and physical properties of the TDP-43 disordered C-terminal domain, several peptide fragments were synthesized and shown that only D1 within D1-4 can form twisted fibrils
6. Both a gain and loss of function of mutant TDP-43 are involved in contributes to Amyotrophic Lateral Sclerosis pathogenesis.
7. These findings suggest that approximately 25-kDa TDP-43 C-terminal fragments are noxious to neurons by a gain of aberrant nuclear function.
8. TDP-43 and TDP-25 are degraded by both proteasome and autophagy with TDP-25 being more regulated.
9. The spectrum of TARDBP mutations and polymorphisms supported the pathological role of TDP-43 in Chinese amyotrophic lateral sclerosis patients.
10. TARDBP variants may result in clinically and neuropathologically heterogeneous phenotypes linked by a common molecular pathology in frontotemporal lobar degeneration.
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000